Elisabetta Loggi

idibaps

H指数:23

被引数:2,478

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Proteomics of immune cells from liver tumors reveals immunotherapy targets

肝脏肿瘤免疫细胞的蛋白质组学揭示免疫治疗靶点

CELL GENOMICS

IF9

2023-06-013

OAAI

Canale, Fernando P.; Neumann, Julia; von Renesse, Janusz; Loggi, Elisabetta; Pecoraro, Matteo; Vogel, Ian; Zoppi, Giada; Antonini, Gaia; Wolf, Tobias; Jin, Wenjie; Zheng, Xiaoqin; La Barba, Giuliano; Birgin, Emrullah; Forkel, Marianne; Nilsson, Tobias; Marone, Romina; Mueller, Henrik; Pelletier, Nadege; Jeker, Lukas T.; Civenni, Gianluca; Schlapbach, Christoph; Catapano, Carlo V.; Seifert, Lena; Seifert, Adrian M.; Gillessen, Silke; Dosso, Sara De; Cristaudi, Alessandra; Rahbari, Nuh N.; Ercolani, Giorgio; Geiger, Roger

Virological Treatment Monitoring for Chronic Hepatitis B

VIRUSES-BASEL

IF3.5

2022-06-245

OAAI

Diagnostic performance of PIVKA-II in patients with hepatocellular carcinoma

CLINICA CHIMICA ACTA

IF2.9

2019-06-010

PREAI

Managing HCV treatment failure and the potential of resistance testing in informing second-line therapy options

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY

IF3.8

2018-10-291

PREAI

Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment

ANNALS OF HEPATOLOGY

IF4.4

2018-01-0146

OAAI

METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY

ATHEROSCLEROSIS

IF5.7

2017-08-010

PREAI

Hepatitis B virus reactivation among hepatitis C patients treated with directacting antiviral therapies in routine clinical practice

JOURNAL OF CLINICAL VIROLOGY

IF3.4

2017-08-0125

PREAI

Worsening of serum lipid profile after direct acting antiviral treatment

DIGESTIVE AND LIVER DISEASE

IF3.8

2017-02-010

OAAI

Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

在现实生活中的患者中，对直接作用的抗病毒失败的多级HCV耐药性提倡量身定制的二线治疗

LIVER INTERNATIONAL

IF5.2

2017-01-2078

PREAI

Di Maio, Velia C.; Cento, Valeria; Lenci, Ilaria; Aragri, Marianna; Rossi, Piera; Barbaliscia, Silvia; Melis, Michela; Verucchi, Gabriella; Magni, Carlo F.; Teti, Elisabetta; Bertoli, Ada; Antonucci, FrancescoPaolo; Bellocchi, Maria C.; Micheli, Valeria; Masetti, Chiara; Landonio, Simona; Francioso, Simona; Santopaolo, Francesco; Pellicelli, Adriano M.; Calvaruso, Vincenza; Gianserra, Laura; Siciliano, Massimo; Romagnoli, Dante; Cozzolongo, Raffaele; Grieco, Antonio; Vecchiet, Jacopo; Morisco, Filomena; Merli, Manuela; Brancaccio, Giuseppina; Di Biagio, Antonio; Loggi, Elisabetta; Mastroianni, Claudio M.; Palitti, Valeria Pace; Tarquini, Pierluigi; Puoti, Massimo; Taliani, Gloria; Sarmati, Loredana; Picciotto, Antonino; Vullo, Vincenzo; Caporaso, Nicola; Paoloni, Maurizio; Pasquazzi, Caterina; Rizzardini, Giuliano; Parruti, Giustino; Craxi, Antonio; Babudieri, Sergio; Andreoni, Massimo; Angelico, Mario; Perno, Carlo F.; Ceccherini-Silberstein, Francesca

Worsening of serum lipid profile after direct acting antiviral treatment

JOURNAL OF HEPATOLOGY

IF33

2017-01-011

OAAI

Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study

LIVER INTERNATIONAL

IF5.2

2016-07-196

PREAI

HEPATITIS C CORE ANTIGEN ASSAY FOR THE MONITORING OF TREATMENT WITH DIRECT ANTIVIRAL AGENTS IN PATIENTS WITH CHRONIC HEPATITIS C

DIGESTIVE AND LIVER DISEASE